0
Il n'y a pas de produit dans le panier !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Accueil > Expositions > Building the Perfect Antibody-based Therapeutic from Selection to Engineering and Manufacturing
  1. Building the Perfect Antibody-based Therapeutic from Selection to Engineering and Manufacturing

    1. September 20th, 2024 • 10 a.m. PT, 1 p.m. ET
    2. Online
    3. ACROBiosystems
    Click the button to enter our raffle.
  2. Guest Speaker

    Linglan Fu

    Linglan Fu, Ph.D.

    Associate Scientist
    Zymeworks

    Eason Lin

    Eason Lin, Ph.D.

    Senior Scientist
    AurekaBio

    Peter Hsueh

    Peter Hsueh, Ph.D.

    Marketing Product Manager
    ACROBiosystems

    Overview

    In this webinar, discover how advanced techniques such as Al-driven candidate selection optimization of antibody sequences, and precise conjugation methods come together to address some of the current challenges in antibody-based therapeutics.

    Some things you’ll learn include:

    - Antibody Engineering with Zymeworks: Learn about how we push the boundary of antibody engineering by optimizing antibody sequences to develop the next generation of antibody-based therapeutics, including antibody-drug conjugates.

    - Strategic Al-based Antibody Selection with Aureka Bio: Learn about how Al can accelerate the selection, synthesis, and characterization of antibody candidates at scale during therapeutic discovery.

    - Precision in Antibody Conjugation with ACROBiosystems: Discover how ACROBiosystems can transform your antibodies into antibody-drug conjugates with various life science tools to conjugate and characterize your ADC.

    Resource download

    Resource download
    Resource download
    Resource download

    Organisers

    Zymeworks
    AurekaBio
    ACRO
New & Hot Products


This web search service is supported by Google Inc.

totop

Laisser un message